Nova price target raised to $220 from $190 at BofA

BofA analyst Vivek Arya raised the firm’s price target on Nova to $220 from $190 and keeps a Buy rating on the shares. March quarter sales were 4% ahead of consensus, with EPS 9% ahead of the Street, noted the analyst, who raised calendar 2024 and 2025 sales estimates by 2% and 4%, respectively, and EPS forecasts by 3% each to $5.46 and $6.30 following the report.